Reply to Kalil et al., "Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?"

Antimicrob Agents Chemother. 2019 Oct 22;63(11):e01347-19. doi: 10.1128/AAC.01347-19. Print 2019 Nov.

¹ Sharp Memorial Hospital, San Diego, California, USA george.sakoulas@sharp.com.
² University of California San Diego School of Medicine, La Jolla, California, USA.
³ Sharp Memorial Hospital, San Diego, California, USA.
⁴ Sharp Grossmont Hospital, La Mesa, California, USA.
⁵ University of Wisconsin School of Pharmacy, Madison, Wisconsin, USA.
⁶ University of Rhode Island College of Pharmacy, Kingston, Rhode Island, USA.
⁷ Henry Ford Hospital, Detroit, Michigan, USA.
⁸ Doctor Evidence, LLC, Santa Monica, California, USA.

No abstract available

Publication types